Search Results - "Bila, Jelena"

A real world multicenter retrospective study on extramedullary disease from Balkan Myeloma Study Group and Barcelona University: analysis of parameters that improve outcome by Beksac, Meral, Seval, Guldane Cengiz, Kanellias, Nicholas, Coriu, Daniel, Rosiñol, Laura, Ozet, Gulsum, Goranova-Marinova, Vesselina, Unal, Ali, Bila, Jelena, Ozsan, Hayri, Ivanaj, Arben, Balić, Lejla Ibricevic, Kastritis, Efstathios, Bladé, Joan, Dimopoulos, Meletios Athanasios

“…Here, we report the outcome of 226 myeloma patients presenting with extramedullary plasmacytoma or paraosseous involvement in a retrospective study conducted…”
Get full text

Development and validation of multivariable predictive model for thromboembolic events in lymphoma patients by Antic, Darko, Milic, Natasa, Nikolovski, Srdjan, Todorovic, Milena, Bila, Jelena, Djurdjevic, Predrag, Andjelic, Bosko, Djurasinovic, Vladislava, Sretenovic, Aleksandra, Vukovic, Vojin, Jelicic, Jelena, Hayman, Suzanne, Mihaljevic, Biljana

“…Lymphoma patients are at increased risk of thromboembolic events but thromboprophylaxis in these patients is largely underused. We sought to develop and…”
Get full text

Efficacy and safety of melflufen plus daratumumab and dexamethasone in relapsed/refractory multiple myeloma: results from the randomized, open-label, phase III LIGHTHOUSE study by Pour, Luděk, Szarejko, Monika, Bila, Jelena, Schjesvold, Fredrik H, Spicka, Ivan, Maisnar, Vladimir, Jurczyszyn, Artur, Grudeva-Popova, Zhanet, Hájek, Roman, Usenko, Ganna, Thuresson, Marcus, Norin, Stefan, Jarefors, Sara, Bakker, Nicolaas A, Richardson, Paul G, Mateos, Maria-Victoria

“…Melphalan flufenamide (melflufen), a first-in-class alkylating peptide-drug conjugate, plus dexamethasone was approved in Europe for use in patients with…”
Get full text

A real world multicenter retrospective study on extramedullary disease from Balkan Myeloma Study Group and Barcelona University: analysis of parameters that improve outcome by Beksac, Meral, Seval, Guldane Cengiz, Kanellias, Nicholas, Coriu, Daniel, Rosiñol, Laura, Ozet, Gulsum, Goranova-Marinova, Vesselina, Unal, Ali, Bila, Jelena, Ozsan, Hayri, Ivanaj, Arben, Balić, Lejla Ibricevic, Kastritis, Efstathios, Bladé, Joan, Dimopoulos, Meletios Athanasios

Get full text

Ocrelizumab associated late-onset neutropenia in the patient with multiple sclerosis: Case report and literature review by Jovicevic, Vanja, Bila, Jelena, Mesaros, Sarlota, Pekmezovic, Tatjana, Drulovic, Jelena

“…Introduction. Ocrelizumab is a recombinant humanized monoclonal antibody that selectively depletes CD20-expressing B cells, which is approved for the treatment…”
Get full text

PB2103: PROGNOSTIC PROFILING OF PATIENTS WITH MULTIPLE MYELOMA: THE GAME OF SCORES‐DOES IT MATTER? by Sretenovic, Aleksandra, Mitrovic, Marko, Vukosavljevic, Nikola, Bukumiric, Zoran, Kecman, Natalija, Balint, Milena Todorovic, Jovanovic, Jelica, Bila, Jelena

Get full text

Gene Mutation Profiles in Primary Diffuse Large B Cell Lymphoma of Central Nervous System: Next Generation Sequencing Analyses by Todorovic Balint, Milena, Jelicic, Jelena, Mihaljevic, Biljana, Kostic, Jelena, Stanic, Bojana, Balint, Bela, Pejanovic, Nadja, Lucic, Bojana, Tosic, Natasa, Marjanovic, Irena, Stojiljkovic, Maja, Karan-Djurasevic, Teodora, Perisic, Ognjen, Rakocevic, Goran, Popovic, Milos, Raicevic, Sava, Bila, Jelena, Antic, Darko, Andjelic, Bosko, Pavlovic, Sonja

“…The existence of a potential primary central nervous system lymphoma-specific genomic signature that differs from the systemic form of diffuse large B cell…”
Get full text

The significance of prognostic profiling in the treatment of patients with multiple myeloma by Mitrović, Marko, Sretenović, Aleksandra, Bila, Jelena

“…Multiple myeloma (MM) is a hematological neoplasia characterized by clonal expansion of the most mature B lymphocytes, plasma cells (Plc), in the bone marrow…”
Get full text

Salvage Therapy With Polatuzumab Vedotin, Bendamustine, and Rituximab Prior to Allogeneic Hematopoietic Transplantation in Patients With Aggressive Lymphomas Relapsing After Therapy With Chimeric Antigen Receptor T-Cells—Report on Two Cases by Gerhardt, Kristin, Jentzsch, Madlen, Georgi, Thomas, Sretenović, Aleksandra, Cross, Michael, Bach, Enrica, Monecke, Astrid, Leiblein, Sabine, Hoffmann, Sandra, Todorović, Milena, Bila, Jelena, Sabri, Osama, Schwind, Sebastian, Franke, Georg-Nikolaus, Platzbecker, Uwe, Vučinić, Vladan

“…Up to 60% of patients with aggressive B-cell lymphoma who receive chimeric antigen receptor (CAR) T-cell therapy experience treatment failure and subsequently…”
Get full text

PB2143: PROGNOSTIC SIGNIFICANCE AND CLINICAL APPLICABILITY OF THE COMORBIDITY INDICES IN PATIENTS WITH MULTIPLE MYELOMA: IMWG AND SARC‐F SCORE by Vukosavljevic, Nikola, Milojevic, Zoran, Markovic, Katarina, Sretenovic, Aleksandra, Mitrovic, Marko, Markovic, Nevenka, Davidovic, Dusica, Pavlovic, Miroslav, Markovic‐Dobrijevic, Tijana, Cakarevic, Marija, Bila, Jelena

Get full text

P956: VALIDATION OF THE SECOND REVISION OF THE INTERNATIONAL STAGING SYSTEM (R2‐ISS) FOR OVERALL SURVIVAL IN MULTIPLE MYELOMA IN A REAL WORLD COHORT: AN ANALYSIS BY THE BALKAN MYELOMA STUDY GROUP (BMSG) by Kastritis, Efstathios, Katodritou, Eirini, Badelita, Sorina, Bila, Jelena, Cengiz Seval, Güldane, Cvetkovic, Zorica, Coriu, Daniel, Spanoudakis, Emmanouil, Dalampira, Dimitra, Sretenovic, Aleksandra, Sevastoudi, Aggeliki, Bojan, Anca, Mitrovic, Marko, Danaila, Catalin, Gavriatopoulou, Maria, Roussou, Maria, Dimopoulos, Meletios A., Beksac, Meral, Terpos, Evangelos

Get full text

25(OH) vitamin D deficiency in lymphoid malignancies, its prevalence and significance. Are we fully aware of it? by Djurasinović, Vladislava T., Mihaljević, Biljana S., Šipetić Grujičić, Sandra B., Ignjatović, Svetlana D., Trajković, Goran, Todorović-Balint, Milena R., Antić, Darko A., Bila, Jelena S., Andjelić, Boško M., Jeličić, Jelena J., Vuković, Vojin M., Nikolic, Aleksandra M., Klek, Stanislaw

“…Introduction Vitamin D has a role in cellular differentiation, proliferation, apoptosis, and angiogenesis and therefore is studied as a prognostic factor in…”
Get full text

P981: DISEASE CHARACTERISTICS AND TREATMENT OUTCOMES OF MYELOMA PATIENTS <50 YEARS OF AGE: AN ANALYSIS OF THE BALKAN MYELOMA STUDY GROUP by Kastritis, Efstathios, Beksac, Meral, Badelita, Sorina, Katodritou, Eirini, Bila, Jelena, Spanoudakis, Emmanouil, Cengiz Seval, Güldane, Cvetkovic, Zorica, Coriu, Daniel, Mitrovic, Marko, Saguna, Carmen, Dalampira, Dimitra, Bojan, Anca, Batinic, Josip, Zver, Samo, Guenova, Margarita, Ivanaj, Arben, Gavriatopoulou, Maria, Terpos, Evangelos, Dimopoulos, Meletios A.

Get full text

FCG (FLIPI, Charlson comorbidity index, and histological grade) score is superior to FLIPI in advanced follicular lymphoma by Mihaljevic, Biljana, Jelicic, Jelena, Andjelic, Bosko, Antic, Darko, Markovic, Olivera, Petkovic, Ivan, Jovanovic, Maja Perunicic, Trajkovic, Goran, Bila, Jelena, Djurasinovic, Vladislava, Sretenovic, Aleksandra, Vukovic, Vojin, Smiljanic, Mihailo, Balint, Milena Todorovic

“…The Follicular Lymphoma International Prognostic Index (FLIPI) is widely used in the identification of risk groups among follicular lymphoma (FL) patients. The…”
Get full text

Influence of applied CD34+ cell dose on the survival of Hodgkin's lymphoma and multiple myeloma patients following autologous stem cell transplants by Todorovic-Balint, Milena, Bila, Jelena, Balint, Bela, Jelicic, Jelena, Djunic, Irena, Antic, Darko, Kraguljac-Kurtovic, Nada, Vujic, Dragana, Mihaljevic, Biljana

“…Background/Aim. Autologous stem cell transplants (ASCTs) improve the rate of overall survival (OS) in patients with hematological malignancies such as multiple…”
Get full text

Ultrastructural and morphometric analysis of enlarged platelets in congenital isolated asplenia by Markovic, Olivera, Martinovic, Tamara, Ciric, Darko, Trpinac, Dusan, Cemerikic-Martinovic, Vesna, Bumbasirevic, Vladimir, Bila, Jelena, Marisavljevic, Dragomir, Kravic-Stevovic, Tamara

“…Introduction. Congenital asplenia is an extremely rare condition that can be separate entity due to a specific defect of spleen development or may occur in the…”
Get full text

FGF-R3 and OPG expression in patient with multiple myeloma following systemic sclerosis: case report and review of the literature by Čolović, Milica, Jurisic, Vladimir, Bila, Jelena, Čolović, Natasa, Palibrk, Vuk

“…The presence of multiple myeloma (MM) in a patient with systemic sclerosis is a rare and unusual occurrence with unclear significance. We report the case of a…”
Get full text

Follicular lymphoma patients with a high FLIPI score and a high tumor burden: a risk stratification model by Andjelić, Boško, Todorović-Balint, Milena, Antić, Darko, Bila, Jelena, Djurašinović, Vladislava, Mihaljević, Biljana

“…The widely accepted Follicular Lymphoma International Prognostic Index (FLIPI) divides patients into three risk groups based on the score of adverse prognostic…”
Get full text

Extramedullary plasmacytoma of the tongue base: a rare presentation of head and neck plasmacytoma by Bila, Jelena, Andjelić, Bosko, Bodrozić, Jelena, Jaković, Ljubomir, Jovanović, Maja Perunicić, Vidović, Ana, Todorović, Milena, Mihaljević, Biljana

“…Special entities like solitary bone plasmocytoma (SBP) or extramedullary plasmacytoma (EMP) can be found in a less than 5% of patients with plasma cell…”
Get full text

Spinal epidural granulocytic sarcoma in non-leukemic patient by ANTIC, Darko, VERSTOVSEK, Srdan, ELEZOVIC, Ivo, GRUJICIC, Dana, GOTIC, Mirjana, BILA, Jelena, PERUNICIC, Maja, JAKOVIC, Ljubomir

Get full text